APLT DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT Feb 18, 2025 10:36PM
APLT DEADLINE TOMORROW: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT Feb 17, 2025 01:10PM
APLT IMPORTANT DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - Feb 16, 2025 12:33PM
APLT DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT Feb 13, 2025 05:44PM
APLT DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT Feb 12, 2025 05:58PM
View Older Stories

Feb 9, 2025 05:13PM APLT FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 18 Deadline in Securitie
Feb 7, 2025 02:06PM ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Feb 3, 2025 06:45PM ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Jan 29, 2025 04:00PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Jan 28, 2025 04:33PM ROSEN, LEADING TRIAL ATTORNEYS, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Jan 23, 2025 03:40PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Jan 22, 2025 03:01PM ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Jan 20, 2025 09:42PM ROSEN, HIGHLY RECOGNIZED INVESTOR RIGHTS COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Jan 19, 2025 09:26PM ROSEN, A LEADING FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Jan 18, 2025 08:29PM ROSEN, NATIONAL TRIAL LAWYERS, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Jan 17, 2025 05:50PM ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Jan 16, 2025 05:44PM ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Jan 14, 2025 11:26PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Jan 13, 2025 11:26PM ROSEN, A LEADING LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Jan 12, 2025 11:26PM ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Jan 11, 2025 05:17PM ROSEN, A HIGHLY REGARDED LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Jan 10, 2025 05:16PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Jan 9, 2025 05:15PM ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Jan 8, 2025 05:10PM ROSEN, A RANKED AND LEADING FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Jan 7, 2025 03:38PM ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Jan 5, 2025 08:08PM ROSEN, A LEADING LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Jan 4, 2025 08:07PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Jan 3, 2025 08:06PM ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Jan 2, 2025 08:05PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Jan 1, 2025 08:00PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Dec 31, 2024 08:00PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Dec 29, 2024 10:39PM ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Dec 28, 2024 10:38PM ROSEN, A LEADING LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Dec 27, 2024 10:37PM ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Dec 26, 2024 10:36PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Dec 25, 2024 10:35PM ROSEN, A LEADING NATIONAL FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Dec 24, 2024 10:34PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Dec 23, 2024 10:33PM ROSEN, A LONGSTANDING LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Dec 22, 2024 10:32PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Purchasers to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Dec 21, 2024 06:40PM ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Applied Therapeutics, Inc. Purchasers to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Dec 20, 2024 06:39PM ROSEN, GLOBALLY RECOGNIZED INVESTOR RIGHTS COUNSEL, Encourages Applied Therapeutics, Inc. Purchasers to Secure Counsel Before Important Deadline in Securities Class Action - APLT
Nov 7, 2024 07:00AM Applied Therapeutics Reports Third Quarter 2024 Financial Results
Nov 5, 2024 07:00AM Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference
Sep 18, 2024 07:02AM Applied Therapeutics (APLT) Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia
Sep 18, 2024 07:00AM Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia
Sep 4, 2024 07:00AM Applied Therapeutics to Participate in Upcoming Investor Conferences
Aug 7, 2024 07:00AM Applied Therapeutics Reports Second Quarter 2024 Financial Results
Jul 1, 2024 07:00AM Applied Therapeutics Added to Russell 3000® Index
May 9, 2024 07:00AM Applied Therapeutics Reports First Quarter 2024 Financial Results
May 7, 2024 07:00AM Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference
Apr 15, 2024 07:03AM Applied Therapeutics (APLT) Appoints Dale Hooks as Chief Commercial Officer
Apr 15, 2024 07:00AM Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
Apr 4, 2024 07:01AM Applied Therapeutics (APLT) to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024
Apr 4, 2024 07:00AM Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024
Mar 28, 2024 04:30PM Applied Therapeutics Inc. (APLT) Provides FDA Update on PDUFA Date for Govorestat
View Older Stories